Kimura Disease: Retrospective Analysis of 53 Cases and Three Mepolizumab-Responsive Cases
This study provided a comprehensive summary and age-stratified analysis of the clinical characteristics of KD, providing valuable insights into its pathophysiology and potential overlapping mechanisms. Additionally, the study presents clinical cases of three patients treated with mepolizumab, highlighting its potential as a promising therapeutic option for the management of KD.
Authors
- Yuanping Shi
- Wenjiao Zhu (ORCID: https://orcid.org/0000-0002-2970-1412)
- Jing Shi (ORCID: https://orcid.org/0000-0002-2277-7684)
- Dingxian He (ORCID: https://orcid.org/0009-0005-9955-7179)
- Xianhui Ning (ORCID: https://orcid.org/0000-0002-9407-2683)
- Yiran Liang (ORCID: https://orcid.org/0000-0002-2404-0408)
- Wei Wang (ORCID: https://orcid.org/0000-0002-8696-9773)
- Jing Zhang (ORCID: https://orcid.org/0000-0003-2265-565X)
- Ling Ye
- Lei Zhang (ORCID: https://orcid.org/0000-0001-7769-7377)
- Xiang Ye (ORCID: https://orcid.org/0000-0002-2283-2591)
- Meiling Jin (ORCID: https://orcid.org/0000-0002-8663-0702)
Institutions
- Sun Yat-sen University (CN)
- Peking University (CN)
- Fudan University (CN)
- Shanghai Ninth People's Hospital (CN)
- Peking University People's Hospital (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jir.s538560
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fudan University